Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial—an open-label, one-year, prospective study—Interim analysis of 32 patients for 24 weeks

OBJECTIVE: To assess the efficacy and safety of abatacept for secondary Sjögren's syndrome (SS) associated with rheumatoid arthritis (RA). METHODS: The primary endpoint of this 1-year, open-labeled, prospective, observational multicenter study of RA-associated secondary SS was the rate of SDAI...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuboi, Hiroto, Matsumoto, Isao, Hagiwara, Shinya, Hirota, Tomoya, Takahashi, Hiroyuki, Ebe, Hiroshi, Yokosawa, Masahiro, Hagiya, Chihiro, Asashima, Hiromitsu, Takai, Chinatsu, Miki, Haruka, Umeda, Naoto, Kondo, Yuya, Ogishima, Hiroshi, Suzuki, Takeshi, Hirata, Shintaro, Saito, Kazuyoshi, Tanaka, Yoshiya, Horai, Yoshiro, Nakamura, Hideki, Kawakami, Atsushi, Sumida, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389760/
https://www.ncbi.nlm.nih.gov/pubmed/25211401
http://dx.doi.org/10.3109/14397595.2014.951144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389760/
https://www.ncbi.nlm.nih.gov/pubmed/25211401
http://dx.doi.org/10.3109/14397595.2014.951144

Ejemplares similares